We have concluded our 11th fiscal year in June 2023, achieving record-breaking sales and net profits thanks to your continued support. In the previous fiscal year, we were responsible for various qualitative research projects in the Healthcare and IT/High Tech markets, conducting participant recruitment and interviews as follows. We deeply appreciate your contribution to our endeavors.

In no particular order below

Patients/carers (hemophilia, myasthenia gravis, pulmonary hypertension, IgA nephropathy, non-small cell lung cancer, primary cholangitis, Crohn’s disease, metastatic castration-resistant prostate cancer, amyotrophic lateral sclerosis, atopic dermatitis, heart failure, melanoma, etc.)
Nurses (neurology, wound care, ICU, HCU, cardiology, psychiatry, orthopedic surgery, surgery, obstetrics and gynecology, endocrinology, etc.)
Pharmacists
Pharmacy owners
Clinical engineers
Clinical laboratory technicians
Clinical radiologists
Sterilization officer
Thoracic surgeon
Respiratory physician
Respiratory surgeon
Anesthetist
Cardiologist
Paramedic physician
Orthopedic surgeon
Vascular surgeon
Pediatrician
Plastic surgeon
Cardiovascular surgeon
Radiologist
Surgeon
Interventional cardiologist
Interventional radiologist
Nephrologist
Urologist
Hepatobiliary-pancreatic surgeon
Gastrointestinal surgeon
Colorectal surgeon
Sleep specialist physician
Otolaryngologist
Psychiatrist
Haemato-oncologist
Oncologist
Rheumatologist
Endocrine and metabolic physician
Ophthalmologist
Hematologist
Pharmaceutical company drug discovery officers
Users of online collaboration tools (financial, government, accommodation, wholesale and manufacturing industries)
Users of online ticketing websites
YouTube creators
Web browser users, etc.